An Outbreak of Mumps in a Population Partially Vaccinated with the Rubini Strain

References

• Bundesamt für Gesundheitswesen. Impfkampagne gegen Masern, Mumps und Röteln. Bull BAG 1987; 8: 60–65
   Google Scholar
• Somaini B. Ziele des Masern/Mumps/Roteln-Impfprogramms. Bull BAG 1988; 3: 31–36
   Google Scholar
• Bundesamt für Gesundheitswesen. Impfkampagne gegen Masern. Mumps und Röteln: Trivalente Masern-Mumps-Röteln Impfstoffe. Bull BAG 1987; 8: 184
   Google Scholar
• Glück R (1991) A novel type of combined measles-mumps-rubella vaccine (HDCV). Virus diseases: the global challenge to health for all. Proceeding of the Second Asia-Pacific Congress of Medical Virology. Nov. 17, 1991, P Thongcharoen, JL Melnick. Mahidol University, BangkokThailand, 22: 185–194
   Google Scholar
• Bundesamt für Gesundheitswesen. Masern-, Mumps-und Röteln-Durehimpfung bei Schulkindern in der Schweiz 1987–1991. Bull BAG 1991; 19: 278–283
   Google Scholar
• Nokes DJ, Anderson RM. Vaccine safety versus vaccine efficacy in mass immunisation programmes. Lancet 1991; 338: 1309–1312
   PubMed Web of Science ®Google Scholar
• Nokes DJ, Anderson RM. Mathematical models of infectious agent transmission and the impact of mass vaccination. Rev Med Microbiol 1992; 3: 187–195
   Google Scholar
• Bundesaml für Gesundheitswesen. Masern-, Mumps-, Röteln-Impfung: Empfehlung des Bundesamtes für Gesundheitswesen. Bull BAG 1994; 38: 650–651
   Google Scholar
• Cochi SL, Preblud SR, Orenslein WA. Perspectives of relative resurgence of mumps in the United States. Am J Dis Child 1988; 142: 499–507
   PubMedGoogle Scholar
• Gunrtner F. The sentinel network of family practitioners in Switzerland: its aims, its methods and its use for public health [thesis]. University of London, London 1990; 1–105
   Google Scholar
• Matter HC, Cloetta J, Zimmermann H. Sentinella Arbeitsgemeinschaft. Measles, mumps, and rubella: monitoring in Switzerland through a sentinel network, 1986–94. J Epidemiol Commun Health 49 Suppl 1995; 1: 4–8
   Google Scholar
• Sentinella. Masern-. Mumps-Röteldurchimpfung bei Schulkindern in der Schweiz. Bull BAG 1991; 278–283
   Google Scholar
• Anderson RM, Crombie JA, Grenfell BT. The epidemiology of mumps in the UK: a preliminary study of virus transmission, herd immunity and the potential impact of immunization. Epidemiol Infect 1987; 99: 65–84
   PubMed Web of Science ®Google Scholar
• Giammanco G, Livolti S, Salemi I, Bilancia GG, Mauro L. Immune response to simultaneous administration of a combined measles, mumps and rubella vaccine with booster doses of diphtheria-tetanus and poliovirus vaccine. Eur J Epidemiol 1993; 9: 199–202
   PubMed Web of Science ®Google Scholar
• Li Volti S, Giammanco-Bilancia G, Grassi M, Garozzo R, Glück R, Giammanco G. Duration of the immune response to MMR vaccine in children of two age-different groups. Eur J Epidemiol 1993; 9: 311–314
   PubMed Web of Science ®Google Scholar
• Popow-Kraupp T, Kundi M, Ambrosch F, Vanura H, Kunz C. A controlled trial for evaluating two live attenuated mumpsmeasles vaccines (Urabe Am9-Schwarz and Jeryl Lynn-Moraten) in young children. J Med Virol 1986; 18: 69–79
   PubMed Web of Science ®Google Scholar
• Hersh BS, Fine P EM, Kent WK, Cochi SL, Kahn L HR, Zell ER, Hays PL, Wood CL. Mumps outbreak in a highly vaccinated population. J Pediatr 1991; 119: 187–193
   PubMed Web of Science ®Google Scholar
• Christenson B, Heller L, Boettiger M. The immunizing effect and reactogenicity of two live attenuated mumps virus vaccines in Swedish schoolchildren. J Biol Standard 1983; 11: 323–331
   PubMedGoogle Scholar
• Sugg WC, Finger JA, Levine RH, Pagano JS. Field evaluation of live virus mumps vaccine. J Pediatr 1968; 72: 461–466
   PubMed Web of Science ®Google Scholar
• Anderson RM, May RM. Directly transmitted infectious diseases: control by vaccination. Science 1982; 215: 1053–1060
   PubMed Web of Science ®Google Scholar
• Briss PA, Fehrs LJ, Parker RA, Wright PF, Sannella EC, Hutcheson RH, Schaffner W. Sustained transmission of mumps in a highly vaccinated population – assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis 1994; 169: 77–82
   PubMed Web of Science ®Google Scholar
• Tabin R, Berclaz J-P, Dupuis G, Peter O. Réponse immune à divers vaccins anti-ourliens. Rev Med Suisse Rom 1993; 113: 981–984
   PubMedGoogle Scholar
• Glück R. Modern approaches to animal cell technology. Butterworth, Sevenoaks 1987, 587–595
   Google Scholar
• Yamanishi K, Takahashi M, Ueda S, Minekawa Y, Ogino T, Suzuki N, Okuno Y, Kan T. Studies of live mumps virus vaccine. V. Development of a new mumps vaccine “AM 9” by plaque cloning. Biken J 1973; 16: 161–166
   PubMedGoogle Scholar
• Boriskin YS, Kaptsova TI, Lotte VD, Skvortsova OI, Örvell C. Laboratory markers for over-attenuation of mumps vaccine virus. Vaccine 1988; 6: 483–488
   PubMed Web of Science ®Google Scholar
• Buynak EB, Hilleman MR. Live attenuated mumps virus vaccine. 1. Vaccine development. Proc Soc Exp Biol Med 1966; 13: 769–775
   Google Scholar
• Stöhle A, Germann D. Mumpsimpfstoffe: Virologische Grundlagen. Soz Präventivmed 1995; 40: 102–109
   PubMedGoogle Scholar
• James JM, Burks AW, Roberson PK, Sampson HA. Safe administration of the measles vaccine to children allergic to eggs. N Engl J Med 1995; 332: 1262–1266
   PubMed Web of Science ®Google Scholar
• Yeo RP, Afzal MA, Forsey T, Rima BK. Identification of a new mumps virus lineage by nucleotide sequence analysis of the SH Gene of 10 different strains. Arch Virol 1993; 128: 371–377
   PubMed Web of Science ®Google Scholar
• Künkel U, Driesel G, Henning U, Gerike E, Willers H, Schreier E. Differentiation of vaccine and wild mumps viruses by polymerase chain reaction and nucleotide sequencing of the SH gene: brief report. J Med Virol 1995; 45: 121–126
   PubMed Web of Science ®Google Scholar
• Ströhle A, Bernasconi C, Germann D. A new mumps virus lineage found in the 1995 mumps outbreak in Western Switzerland identified by nucleotide sequence analysis of the SH-gene: brief report. Arch Virol, In press
   Google Scholar
• Ströhle A. A mumps epidemic in previously vaccinated children [thesis]. University of Bern, Bern 1996, 1–152
   Google Scholar
• Germann D, Ströhle A, Eggenberger K, Matter L. An outbreak of mumps in a highly vaccinated population. IXth International Congress on Virology 1993; 213(abstract), Glasgow:()
   Google Scholar
• Biedel CW. Recurrent mumps parotitis following natural infection and immunization. Am J Dis Child 1975; 132: 678–680
   Google Scholar
• Gut JP, Lablache C, Behr S, Kirn A. Symptomatic mumps virus reinfections. J Med Virol 1995; 45: 17–23
   PubMed Web of Science ®Google Scholar
• Rabo E, Taranger J. Scandinavian model for eliminating measles, mumps and rubella. Br Med J 1984; 289: 1402–1404
   PubMed Web of Science ®Google Scholar
• Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K. The elimination of indigenous measles, mumps, and rubella from finland by a 12-year, two dose vaccination program. N Engl J Med 1994; 331: 1397–1402
   PubMed Web of Science ®Google Scholar